About Us

Our purpose is to provide products and services to improve the quality of life of people. We use science and technology to address existing healthcare issues.

History

80 Years of Yuyu Pharma

Over 80 years Yuyu has focused on patients and developing new medicines. The company's purpose is to provide products and services to improve the quality of life of people. We use science and technology to address existing healthcare issues.

1941
-2020

Yuyu’s 80 Years of History PDF

Next 100 years, a starting point for a new future.

2022 ~ 2014

2022

Released first generic 'Nagran ODT'

YP-P10, a new drug for the treatment of dry eye, received FDA approval for its Phase 2 clinical trial

Designated by the city of Jecheon, Chungbuk as a “female-friendly workplace

2021

Received an “A” grade evaluation from Korea’s Fair Trade Commission

Yuyu celebrated the 80th anniversary of its establishment

Established collaborative research partnership with UCLA University (USA) for the treatment of multiple sclerosis

Yuyu received certification for its Global Anti-Corruption Management System

2020

Accumulated sales of First Generic Newmacor exceed 40 million capsules

Establishment of new and renewable energy facilities in Jecheon Factory

Introduced to CNN as a social contribution company related to COVID-19

Appointment of CEO Wonsang Yu as president

Establishment of Yuyu Medicals

2019

Appointment of CEO Wonsang Yu

The 100th anniversary of the founder Teckhan Yu's birthday

Selected as Innovative Pharmaceutical Company in Asia Pacific

2018

Seoul office building remodeling completed

Signed MOU with Korean Society of Osteoporosis and Korea Women's Health and Osteoporosis Foundation

Selected as an excellent company for youth jobs in Chungcheongbuk-do

2017

Expansion of the Central Research Center

2015

Released first generic 'Newmacor'

Certified as an excellent family-friendly company by the Ministry of Gender Equality and Family

2014

Awarded a prestigious longevity company by the Ministry of Trade, Industry and Energy

With advanced systems and quality control of global production
Power to innovate management to lay the foundation for a 'second leap'

2013 ~ 2000

2013

Selected as an excellent employment company on the 7th Chungbuk Entrepreneur's Day (Governor's Commendation)

2012

Signed export MOU with Huanghua Group in China

Signed LOI with Bio-Pharmaceuticals, Sdn. Bhd. in Malaysia

Exported osteoporosis treatment drug 'Maxmarvil' to Thailand

Marketing using big data for 'Venoplus Gel' is the first of its kind in the Korea pharmaceutical industry

2011

70th anniversary event, Yuyu celebrated the 70th anniversary of its establishment

2010

Released antidepressant over-the-counter drug 'Noiromin'

Release of vitamin C 'YUPANC pop'

2009

Opened Chuncheon Research Center

Release of chronic respiratory infection treatment product 'Umcamin syrup'

'Yuclid' won the Technology Award at the New Drug Development Research Association New Drug Development Awards

2008

Changed company name to Yuyu Pharma

Release of an improved antiplatelet drug 'Yuclid'

Establishment of International Scientific Standard (ISS)

Chairman Seungpil Yu received the Presidential Citation on Taxpayers' Day

2007

Release of intestinal medicine 'Syubaton'

Contract with Swiss Zeller to introduce 'ZE440', a treatment for perimenstrual syndrome

2006

Relocated to the newly-constructed Jecheon Factory

Establishment of Yuyu Healthcare

Establishment of Yuyu Teijin Medicare joint venture

2004

Released an improved new drug for osteoporosis treatment 'Maxmarvil'

2003

Chairman Seungpil Yu received the National Order of Merit, Moran Medal

2001

Seungpil Yu appointed as Chairman of the Korea Pharmaceutical Association

Release of nasal cleanser 'PHYSIOMER'

Management innovation for diversification and globalization President Yoo Seung-pil's inauguration and internationalization strategy.

1999 ~ 1987

1998

Technical alliance with Gardo of Argentina (release of osteoporosis treatment 'Mavil tablet')

1997

Obtained manufacturing license for Ginkgo biloba extract for the first time in Korea

1996

Acquired a patent for the manufacturing method of Ginkgo biloba extract

1993

Released 'Solong Capsule', a gastric ulcer treatment with Japan's Taisho

'Tanamin tablet' Germany Dr. Willmar Schwabe with 'EGb761' supply contract, released in Korea

1992

Completion of Seoul office building in Sindang-dong

1991

The release of the biopharmaceutical 'Salbiwon' under an exclusive supply contract with Japan's Kokando

1989

Establishment of the Central Research Center (the 17th accreditation by the Ministry of Science and Technology)

1988

Establishment of Yuyu Calmic, a joint venture with Rentokil of the United Kingdom

1987

Seungpil Yu appointed as President of Yuyu Pharma

Improve by attracting foreign capital, disclosure, and rationalization of management
Challenge to synthesize raw materials such as pars

1986 ~ 1961

1986

Technical alliance with Sanofi group of France (release of blood circulation improving agent 'Clid')

Technical alliance with Schwabe of West Germany (release of brain and peripheral circulation improving agent 'Tanamin')

1984

Establishment of Yuyu Fumakilla, a joint venture between Korea and Japan

1982

Technical alliance with Taisho of Japan (release of muscle relaxant 'Rinlaxer')

Changgi Jeon appointed as President of Yuyu Pharma

1981

Adoption of the Chairman-President system. Teckhan Yu appointed as Chairman and Gwangsu Go appointed as President

Technical alliance with Dainippon of Japan (release of anemia treatment 'Burutal Injection')

1976

Technical alliance with Siegteied of Switzerland (release of pain reliever 'Spasla')

1975

Disclosure of enterprises, listing stocks, and establishment of trade unions

Technical partnership with West Germany Dr. Willmar Schwabe (release of a treatment for swelling 'Venoplant')

Technical alliance with Maiji seika of Japan (release of antibiotic 'Maymycin')

1973

Established Yuyu Cultural Foundation

1970

Establishment of Korea Upjohn, a joint venture between Korea and the USA

1968

Technical alliance with Upjohn of the USA (introduced antibiotic new drug 'Lincocin')

1967

Release of 'YUPANC A'

1966

Developed 'Yuyumethionine (DL methionine)' and released 'VENAPOLLO A Soft Capsule'

1965

Development of 'VENAPOLLO', the first soft capsule nutritional supplement in Korea

1962

Released vitamin C formulation 'YUPANC'

It took the lead in establishing 'Yuyu industry' and advancing pharmaceutical technology.
Development of 'Uvita'

1960 ~ 1953

1959

Completion of Anyang factory

1957

Changed company name to Yuyu Industrial Co., Ltd.

1957

Produced 'VitaM Tablet', a multivitamin drug for the first time in Korea

1956

Produced 'Furantival tablet', a psychoactive drug

1955

Production of the tuberculosis drug "Eupaszit"

1953

Changed company name to Yuhan Industrial Co., Ltd., purchased its headquarters in Chungmu-ro, Jung-gu, Seoul, and started manufacturing medicine.

A president who is well versed in the health of his fellow countrymen.

1952 ~ 1941

1952

Yuyu’s founder, Chairman Teckhan Yu, elected as the fourth Chairman of the Korean Pharmaceutical Industry Association

1941

Founder Teckhan Yu establishes Yuyu Trading Co., Ltd. (Yuyu Pharma)

Brand STORY

We introduce Yuyu Pharma brands that make a difference
in happiness with healthy beauty.

view More